Skip to main content

Supreme Court says Justice Ginsburg treated for malignant tumor; no further treatment needed at this time

WASHINGTON (AP) — The Supreme Court says Justice Ruth Bader Ginsburg has completed radiation therapy for a tumor on her pancreas and there is no evidence of the disease remaining.

The court said Friday the tumor was “treated definitively and there is no evidence of disease elsewhere in the body.”

In a statement, the court said a biopsy performed July 31 confirmed a “localized malignant tumor.” The court said Ginsburg does not need any additional treatment but will continue to have periodic blood tests and scans.

The court said Ginsburg canceled an annual summer visit to Santa Fe but has otherwise maintained an active schedule during treatment.

Ginsburg, who is 86, has had several bouts with cancer beginning in 1999. In December, 2018, she had surgery for cancerous growths on her left lung.

Between prices and a diarrhea-causing parasite, lettuce is causing hard times at some restaurants

It’s been a choppy year for restaurants that lean into lettuce. Lettuce prices rose sharply in the first half of 2026 due to hot weather in Arizona, where about one-third of America’s lettuce is grown. Now, restaurants are dealing with the fallout from a cyclospora outbreak linked to shredded lettuce that has sickened thousands of Americans. Taco Bell will likely see the biggest sales impact from the outbreak, which began in late June. Federal health officials first tied the outbreak to shredded iceberg lettuce served at Taco Bell restaurants in Indiana, Kentucky, Michigan, Ohio and West Virginia. Later, the U.S. Food and Drug Administration said customers in Illinois, Kansas, Oklahoma and Pennsylvania were also affected. Taco Bell said on July 17 that it had voluntarily removed shredded iceberg lettuce supplied by Taylor Farms from its U.S. restaurants. But its customer volume has suffered. As of July 23, Taco Bell visits were 21% lower than average across the U.S., according to Placer.ai, a market research company.
Read Next Story